The synthetic retinoid ST1926 attenuates prostate cancer growth and potentially targets prostate cancer stem‐like cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The synthetic retinoid ST1926 attenuates prostate cancer growth and potentially targets prostate cancer stem‐like cells
Authors
Keywords
-
Journal
MOLECULAR CARCINOGENESIS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-03-19
DOI
10.1002/mc.23004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Sphere-Formation Assay: Three-Dimensional in vitro Culturing of Prostate Cancer Stem/Progenitor Sphere-Forming Cells
- (2018) Hisham F. Bahmad et al. Frontiers in Oncology
- Antitumor Effect of the Atypical Retinoid ST1926 in Acute Myeloid Leukemia and Nanoparticle Formulation Prolongs Lifespan and Reduces Tumor Burden of Xenograft Mice
- (2017) Leeanna El-Houjeiri et al. MOLECULAR CANCER THERAPEUTICS
- Use of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells
- (2016) Jan S. Moreb et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Primary versus castration-resistant prostate cancer: modeling through novel murine prostate cancer cell lines
- (2016) Georges Daoud et al. Oncotarget
- The synthetic retinoid ST1926 as a novel therapeutic agent in rhabdomyosarcoma
- (2015) Hussein Basma et al. INTERNATIONAL JOURNAL OF CANCER
- ST1926, an orally active synthetic retinoid, induces apoptosis in chronic myeloid leukemia cells and prolongs survival in a murine model
- (2015) Rihab R. Nasr et al. INTERNATIONAL JOURNAL OF CANCER
- Inhibitory action of pristimerin on hypoxia-mediated metastasis involves stem cell characteristics and EMT in PC-3 prostate cancer cells
- (2015) JIANWEI ZUO et al. ONCOLOGY REPORTS
- Metformin and Ara-a Effectively Suppress Brain Cancer by Targeting Cancer Stem/Progenitor Cells
- (2015) Tarek H. Mouhieddine et al. Frontiers in Neuroscience
- Preclinical efficacy of the synthetic retinoid ST1926 for treating adult T-cell leukemia/lymphoma
- (2014) H. El Hajj et al. BLOOD
- Unlocking the potential of retinoic acid in anticancer therapy
- (2014) T Schenk et al. BRITISH JOURNAL OF CANCER
- Retinoids and breast cancer: From basic studies to the clinic and back again
- (2014) Enrico Garattini et al. CANCER TREATMENT REVIEWS
- Cancer Stem Cells in Prostate Cancer Chemoresistance
- (2014) Jie Ni et al. CURRENT CANCER DRUG TARGETS
- Berberis libanotica Ehrenb Extract Shows Anti-Neoplastic Effects on Prostate Cancer Stem/Progenitor Cells
- (2014) Rabih El-Merahbi et al. PLoS One
- Retinoids and their biological effects against cancer
- (2013) Fatemeh Alizadeh et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
- (2013) T Karantanos et al. ONCOGENE
- New insights into the molecular mechanisms underlying sensitivity/resistance to the atypical retinoid ST1926 in acute myeloid leukaemia cells: The role of histone H2A.Z, cAMP-dependent protein kinase A and the proteasome
- (2012) Maddalena Fratelli et al. EUROPEAN JOURNAL OF CANCER
- Retinoids, Retinoic Acid Receptors, and Cancer
- (2011) Xiao-Han Tang et al. Annual Review of Pathology-Mechanisms of Disease
- Self-Renewing Pten-/-TP53-/- Protospheres Produce Metastatic Adenocarcinoma Cell Lines with Multipotent Progenitor Activity
- (2011) Wassim Abou-Kheir et al. PLoS One
- From carrot to clinic: an overview of the retinoic acid signaling pathway
- (2010) Maria Theodosiou et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Characterizing the Contribution of Stem/Progenitor Cells to Tumorigenesis in the Pten−/−TP53−/− Prostate Cancer Model
- (2010) Wassim G. Abou-Kheir et al. STEM CELLS
- Development and validation of a liquid chromatography–tandem mass spectrometry method for the determination of ST1926, a novel oral antitumor agent, adamantyl retinoid derivative, in plasma of patients in a Phase I study
- (2009) Federica Sala et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Tumour-initiating cells: challenges and opportunities for anticancer drug discovery
- (2009) Bin-Bing S. Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- Atypical retinoids ST1926 and CD437 are S-phase-specific agents causing DNA double-strand breaks: significance for the cytotoxic and antiproliferative activity
- (2008) C. Valli et al. MOLECULAR CANCER THERAPEUTICS
- Identification of cells initiating human melanomas
- (2008) Tobias Schatton et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started